Causeway Capital Management LLC Novartis Ag Transaction History

Causeway Capital Management LLC

  • $3.04 Billion
  • Q3 2024

A detailed history of Causeway Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Causeway Capital Management LLC holds 7,382 shares of NVS stock, worth $738,421. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,382
Previous 202,335 96.35%
Holding current value
$738,421
Previous $21.5 Million 96.06%
% of portfolio
0.03%
Previous 0.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$106.13 - $120.89 $20.7 Million - $23.6 Million
-194,953 Reduced 96.35%
7,382 $849,000
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $3.44 Million - $3.99 Million
-37,133 Reduced 15.51%
202,335 $21.5 Million
Q1 2024

May 15, 2024
BUY
$95.27 - $108.47 $2.89 Million - $3.3 Million
30,379 Added 14.53%
239,468 $23.2 Million
Q4 2023

Feb 14, 2024
BUY
$92.27 - $101.54 $2.04 Million - $2.24 Million
22,070 Added 11.8%
209,089 $21.1 Million
Q3 2023

Nov 09, 2023
SELL
$94.73 - $105.13 $3.65 Million - $4.05 Million
-38,529 Reduced 17.08%
187,019 $19 Million
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $1.87 Million - $2.11 Million
-20,159 Reduced 8.2%
225,548 $22.8 Million
Q1 2023

May 12, 2023
BUY
$80.03 - $92.81 $1.83 Million - $2.12 Million
22,875 Added 10.27%
245,707 $22.6 Million
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $3.63 Million - $4.44 Million
-47,998 Reduced 17.72%
222,832 $20.2 Million
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $3.1 Million - $3.62 Million
-41,511 Reduced 13.29%
270,830 $20.6 Million
Q2 2022

Aug 15, 2022
SELL
$80.52 - $93.75 $6.39 Million - $7.45 Million
-79,421 Reduced 20.27%
312,341 $26.4 Million
Q1 2022

May 13, 2022
BUY
$80.11 - $90.62 $784,677 - $887,622
9,795 Added 2.56%
391,762 $34.4 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $1.53 Million - $1.69 Million
-19,149 Reduced 4.77%
381,967 $33.4 Million
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $2.12 Million - $2.46 Million
-25,866 Reduced 6.06%
401,116 $32.8 Million
Q2 2021

Aug 13, 2021
BUY
$85.24 - $94.15 $2.53 Million - $2.79 Million
29,624 Added 7.46%
426,982 $39 Million
Q1 2021

May 14, 2021
BUY
$83.5 - $98.47 $7.66 Million - $9.04 Million
91,780 Added 30.03%
397,358 $34 Million
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $736,980 - $891,419
-9,440 Reduced 3.0%
305,578 $28.9 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $917,339 - $1.02 Million
-11,168 Reduced 3.42%
315,018 $27.4 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $44,349 - $49,922
-548 Reduced 0.17%
326,186 $28.5 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $2.32 Million - $3.25 Million
32,835 Added 11.17%
326,734 $26.9 Million
Q4 2019

Feb 14, 2020
BUY
$84.35 - $95.37 $3.04 Million - $3.44 Million
36,049 Added 13.98%
293,899 $27.8 Million
Q3 2019

Nov 14, 2019
SELL
$85.54 - $94.26 $1.67 Million - $1.84 Million
-19,489 Reduced 7.03%
257,850 $22.4 Million
Q2 2019

Aug 14, 2019
SELL
$75.4 - $92.8 $406,481 - $500,284
-5,391 Reduced 1.91%
277,339 $25.3 Million
Q1 2019

May 15, 2019
SELL
$75.32 - $86.15 $757,568 - $866,496
-10,058 Reduced 3.44%
282,730 $27.2 Million
Q4 2018

Feb 14, 2019
SELL
$73.66 - $82.02 $11.6 Million - $12.9 Million
-157,344 Reduced 34.96%
292,788 $25.1 Million
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $791,900 - $915,996
-11,830 Reduced 2.56%
450,132 $38.8 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $3.3 Million - $3.73 Million
50,885 Added 12.38%
461,962 $34.9 Million
Q1 2018

May 15, 2018
BUY
$70.39 - $84.15 $5.16 Million - $6.17 Million
73,335 Added 21.71%
411,077 $33.2 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $1.97 Million - $2.11 Million
27,228 Added 8.77%
337,742 $28.4 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $23 Million - $24 Million
310,514
310,514 $26.7 Million

Others Institutions Holding NVS

# of Institutions
1,427
Shares Held
130M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $215B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Causeway Capital Management LLC Portfolio

Follow Causeway Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Causeway Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Causeway Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email